Premium
Association between multidisciplinary team care approach and survival rates in patients with oral cavity squamous cell carcinoma
Author(s) -
Liao ChunTa,
Kang ChungJan,
Lee LiYu,
Hsueh Chuen,
Lin ChienYu,
Fan KangHsing,
Wang HungMing,
Ng ShuHang,
Lin ChihHung,
Tsao ChungKan,
Fang TuanJen,
Huang ShiangFu,
Chang KaiPing,
Chang YaLan,
Yang Lan Yan,
Yen TzuChen
Publication year - 2016
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.24276
Subject(s) - medicine , oral cavity , basal cell , adjuvant , multidisciplinary team , adjuvant therapy , head and neck , head and neck squamous cell carcinoma , overall survival , gastroenterology , oncology , surgery , head and neck cancer , chemotherapy , dentistry , cancer , nursing
Background The purpose of this study was to investigate whether multidisciplinary team care (MDTC) is associated with outcomes in oral cavity squamous cell carcinoma (SCC). Methods We retrospectively examined 1616 patients with oral cavity SCC who underwent radical surgery between 1996 and 2011. The study participants were classified into 2 subgroups according to the use of MDTC. Results Five‐year outcomes were significantly better in the MDTC group than in the no‐MDTC group (neck control, 88% vs 84%, p = .0397; disease‐specific survival [DSS], 83% vs 78%, p = .0114; and overall survival [OS], 70% vs 64%, p = .0002, respectively). Among patients who were scheduled to undergo adjuvant therapy, the number who completed their adjuvant treatment was significantly higher in the MDTC group than in the no‐MDTC group (90% vs 60% to 70%, p < .001). Conclusion The association of MDTC with improved outcomes may be potentially explained by a better therapeutic alliance between the patient and the tumor board, and/or a greater thoroughness in clinical management. © 2016 Wiley Periodicals, Inc. Head Neck 38 : E1544–E1553, 2016